Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
210 studies found for:    psoriatic arthritis | psoriatic arthritis
Show Display Options
Rank Status Study
21 Unknown  Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Open label H.P. Acthar Gel
22 Completed
Has Results
Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: AIN457;   Biological: Placebo
23 Completed HUmira in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Adalimumab
24 Terminated Study of Efficacy, Safety and Effect on Radiographic Progession of Brodalumab in Subjects With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: 210 mg brodalumab;   Drug: 140 mg brodalumab;   Drug: Placebo
25 Completed A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Alefacept;   Drug: Methotrexate;   Drug: Placebo
26 Recruiting PET/CT in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Radiation: FDG-PET/CT scan
27 Recruiting A Multicenter Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis.
Condition: Psoriatic Arthritis
Interventions: Other: Placebo;   Drug: Bimekizumab
28 Withdrawn Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine
Condition: Psoriatic Arthritis
Intervention: Biological: adalimumab (Humira)
29 Completed
Has Results
REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
Condition: Psoriatic Arthritis
Intervention: Drug: Etanercept
30 Completed Rituxan With or Without Methotrexate in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Rituximab
31 Completed Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib 5 mg BID;   Drug: Tofacitinib 10 mg BID;   Drug: Adalimumab;   Drug: Placebo
32 Active, not recruiting Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Secukinumab (AIN457);   Drug: Placebo
33 Completed A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Adalimumab (HUMIRA®)
34 Completed Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Infliximab;   Drug: Etanercept
35 Active, not recruiting Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Guselkumab;   Drug: Ustekinumab;   Drug: Placebo
36 Completed Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
Condition: Psoriatic Arthritis
Interventions: Drug: Tofacitinib;   Other: Placebo
37 Recruiting Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Other: Pain and US assessment
38 Completed
Has Results
Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Secukinumab (75 mg);   Drug: Secukinumab (150 mg);   Drug: Placebo Comparator
39 Completed Phase II Study With CC-10004 in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: CC-10004;   Drug: Matching Placebo
40 Completed Effect of Exercise and Diet on Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Other: Diet;   Other: Exercise;   Other: Diet and Exercise;   Other: Healthy Lifestyle (Control) Group

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.